These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 25322692)

  • 1. Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology.
    Pontarollo G; Bonjour M; Walter T; Pioche M; Lavrut PM; Rabeyrin M; Hervieu V; Fenouil T
    Virchows Arch; 2024 Aug; 485(2):233-244. PubMed ID: 38273213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractal and textural imaging identify new subgroups of patients with colorectal cancer based on biophysical properties of the cancer cells.
    Karri S; Aviel-Ronen S; Firer MA
    Pathol Res Pract; 2022 Oct; 238():154040. PubMed ID: 36057191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for quantifying Crohn's-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer.
    Xu Y; Yang S; Zhu Y; Yao S; Li Y; Ye H; Ye Y; Li Z; Wu L; Zhao K; Huang L; Liu Z
    Comput Struct Biotechnol J; 2022; 20():5586-5594. PubMed ID: 36284712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Crohn's-like lymphoid reaction density: a new artificial intelligence quantified prognostic immune index in colon cancer.
    Zhao M; Yao S; Li Z; Wu L; Xu Z; Pan X; Lin H; Xu Y; Yang S; Zhang S; Li Y; Zhao K; Liang C; Liu Z
    Cancer Immunol Immunother; 2022 May; 71(5):1221-1231. PubMed ID: 34642778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma.
    Kim Y; Bae JM; Kim JH; Cho NY; Kang GH
    J Pathol Transl Med; 2021 Jan; 55(1):53-59. PubMed ID: 33238662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.
    Lee JA; Yoo SY; Oh HJ; Jeong S; Cho NY; Kang GH; Kim JH
    Cancer Immunol Immunother; 2021 Jan; 70(1):47-59. PubMed ID: 32623478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.
    Oyanagi H; Shimada Y; Nagahashi M; Ichikawa H; Tajima Y; Abe K; Nakano M; Kameyama H; Takii Y; Kawasaki T; Homma KI; Ling Y; Okuda S; Takabe K; Wakai T
    Histopathology; 2019 May; 74(6):873-882. PubMed ID: 30636020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
    Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
    Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.
    Yamada R; Yamaguchi T; Iijima T; Wakaume R; Takao M; Koizumi K; Hishima T; Horiguchi SI
    Int J Clin Oncol; 2018 Jun; 23(3):504-513. PubMed ID: 29327160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
    Park HE; Kim JH; Cho NY; Lee HS; Kang GH
    Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic risk stratification of stage IIB colorectal cancer.
    Komori K; Kinoshita T; Oshiro T; Ito S; Abe T; Senda Y; Misawa K; Ito Y; Uemura N; Natsume S; Kawakami J; Ouchi A; Tsutsuyama M; Hosoi T; Shigeyoshi I; Akazawa T; Hayashi D; Tanaka H; Shimizu Y
    Surg Today; 2017 Aug; 47(8):934-939. PubMed ID: 28039532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards tumor immunodiagnostics.
    Kourea H; Kotoula V
    Ann Transl Med; 2016 Jul; 4(14):263. PubMed ID: 27563650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers.
    Kim JH; Park HE; Cho NY; Lee HS; Kang GH
    Br J Cancer; 2016 Aug; 115(4):490-6. PubMed ID: 27404452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.
    Kim JH; Kim KJ; Bae JM; Rhee YY; Cho NY; Lee HS; Kang GH
    J Clin Pathol; 2015 Jan; 68(1):22-8. PubMed ID: 25322692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective criteria for crohn-like lymphoid reaction in colorectal cancer.
    Ueno H; Hashiguchi Y; Shimazaki H; Shinto E; Kajiwara Y; Nakanishi K; Kato K; Maekawa K; Miyai K; Nakamura T; Yamamoto J; Hase K
    Am J Clin Pathol; 2013 Apr; 139(4):434-41. PubMed ID: 23525613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and significance of colorectal cancer associated lymphoid reaction.
    Väyrynen JP; Sajanti SA; Klintrup K; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
    Int J Cancer; 2014 May; 134(9):2126-35. PubMed ID: 24154855
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.